Eyepoint Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $13M | 568k | 23.11 |
| 2023-09-30 | $4.8M | 601k | 7.99 |
| 2023-06-30 | $3.7M | 427k | 8.70 |
| 2023-03-31 | $2.1M | 703k | 2.94 |
| 2022-12-31 | $2.7M | 763k | 3.50 |
| 2022-06-30 | $7.0M | 888k | 7.87 |
| 2022-03-31 | $11M | 871k | 12.15 |
| 2021-12-31 | $7.6M | 622k | 12.24 |
| 2021-09-30 | $407k | 39k | 10.41 |
| 2021-03-31 | $1.4M | 138k | 10.16 |